(Q33251433)

English

Everolimus inhibits glomerular endothelial cell proliferation and VEGF, but not long-term recovery in experimental thrombotic microangiopathy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Everolimus inhibits glomerular endothelial cell proliferation and VEGF, but not long-term recovery in experimental thrombotic microangiopathy (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

0 references

Dontscho Kerjaschki

5

object named as

Dontscho Kerjaschki

0 references

Christoph Daniel

object named as

Christoph Daniel

2

0 references

Karlhans Endlich

1 reference

ORCID Public Data File 2021

author name string

Katja Keller

1

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Harald Schöcklmann

3

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Karl-Hans Endlich

4

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Richard J Johnson

6

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Christian Hugo

7

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

language of work or name

0 references

publication date

20 July 2006

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Nephrology Dialysis Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

2724-2735

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Rapamycin-associated post-transplantation glomerulonephritis and its remission after reintroduction of calcineurin-inhibitor therapy

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL340

21 January 2018

Investigation of pediatric renal transplant recipients with heavy proteinuria after sirolimus rescue

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL340

21 January 2018

Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL340

21 January 2018

Acute rapamycin nephrotoxicity in native kidneys of patients with chronic glomerulopathies

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL340

21 January 2018

Mechanisms of everolimus-induced glomerulosclerosis after glomerular injury in the rat.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL340

21 January 2018

SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL340

21 January 2018

Effect of rapamycin and FK506 on mesangial cell proliferation

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL340

21 January 2018

A new model of renal microvascular endothelial injury

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL340

21 January 2018

Sirolimus-induced thrombotic microangiopathy in a renal transplant recipient

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL340

21 January 2018

Thrombotic micro-angiopathy with sirolimus-based immunosuppression: potentiation of calcineurin-inhibitor-induced endothelial damage?

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL340

21 January 2018

De novo hemolytic uremic syndrome after kidney transplantation in patients treated with cyclosporine-sirolimus combination

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL340

21 January 2018

Sirolimus-induced thrombotic microangiopathy is associated with decreased expression of vascular endothelial growth factor in kidneys

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL340

21 January 2018

De novo hemolytic-uremic syndrome/thrombotic microangiopathy in renal transplant patients receiving calcineurin inhibitors: role of sirolimus

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL340

21 January 2018

Five tumor necrosis factor-inducible cell adhesion mechanisms on the surface of mouse endothelioma cells mediate the binding of leukocytes

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL340

21 January 2018

VEGF induces proliferation, migration, and TGF-beta1 expression in mouse glomerular endothelial cells via mitogen-activated protein kinase and phosphatidylinositol 3-kinase

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL340

21 January 2018

Stable expression of nephrin and localization to cell-cell contacts in novel murine podocyte cell lines

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL340

21 January 2018

The glomerular response to injury: progression or resolution?

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL340

21 January 2018

The cytoskeletal linking proteins, moesin and radixin, are upregulated by platelet-derived growth factor, but not basic fibroblast growth factor in experimental mesangial proliferative glomerulonephritis

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL340

21 January 2018

A role for uric acid in the progression of renal disease

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL340

21 January 2018

Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL340

21 January 2018

The rapamycin derivative RAD inhibits mesangial cell migration through the CDK-inhibitor p27KIP1.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL340

21 January 2018

Antisense oligonucleotides against thrombospondin-1 inhibit activation of tgf-beta in fibrotic renal disease in the rat in vivo.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL340

21 January 2018

Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL340

21 January 2018

Extraglomerular origin of the mesangial cell after injury. A new role of the juxtaglomerular apparatus

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL340

21 January 2018

VEGF(165) mediates glomerular endothelial repair

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL340

21 January 2018

Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL340

21 January 2018

Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL340

21 January 2018

The role of VEGF-A in glomerular development and function

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL340

21 January 2018

Rapamycin is an effective inhibitor of human renal cancer metastasis.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL340

21 January 2018

Integrin (alpha 6 beta 4) regulation of eIF-4E activity and VEGF translation: a survival mechanism for carcinoma cells

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL340

21 January 2018

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL340

21 January 2018

Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL340

21 January 2018

Rapamycin reduces expression of fibrosis-associated genes in an experimental model of renal ischaemia reperfusion injury

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL340

21 January 2018

The effect of combined rapamycin/cyclosporine on the changes in pro-fibrotic gene expression that occur during the development of allograft vasculopathy in rats, compared with cyclosporine or rapamycin in isolation

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL340

21 January 2018

Lymphatic Microvessels in the Rat Remnant Kidney Model of Renal Fibrosis: Aminopeptidase P and Podoplanin Are Discriminatory Markers for Endothelial Cells of Blood and Lymphatic Vessels

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL340

21 January 2018

Identifiers

10.1093/NDT/GFL340

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33251433&oldid=1619755001"